HIGH SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A STRONG, INDEPENDENT PREDICTOR OF THE RISK OF WORSENING PROTEINURIA AND CKD PROGRESSION IN STAGE 2-5 CKD PATIENTS